Half-life
Applied topically; penetration and systemic absorption minimal
Evidence Level
Preliminary
Mechanism of Action
Competes with SNAP-25 at SNARE complex, interfering with acetylcholine vesicle fusion at neuromuscular junction. Reduces muscle contraction frequency that leads to expression lines.
Published Research Ranges & Study Context
Studies have administered: Topical concentrations 4–10% in research formulations
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
In vitro studies show reduction in SNARE complex formation. Clinical trials show modest reduction in wrinkle depth with topical application vs. placebo.
Preliminary
Primarily preclinical + case reports
Side Effects Observed in Research
Generally well-tolerated topically; minimal systemic exposure expected
Available Configurations (SKU Reference)
NP810
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on SNAP-8 — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.